Robert Whitfield MD explains a clinical protocol for preparing patients for fat-transfer procedures by assessing and reducing bodily 'toxicity'. He describes using a urine toxicity test to measure expressed toxins after pre-treatment with specific supplements, plus blood and stool testing (food sensitivities and gut microbiome) and evaluation of functional genomics and hormone balance. Preparation culminates in a phase-one detox using the Cellcore supplement line to lower inflammation and improve outcomes for fat transfer.
Chapters
So I then will try to assess how much toxicity they face, and that's through a urine toxicity test. So we try to get each patient prepared with supplementation to express those into their urine. And we use our supplements to lower inflammation and to express those toxins, our vitamin D3K2, our liposomal B complex, our liposomal vitamin C, and then our oral, oral liposomal glutathione. So you're, you're trying to get these things to be expressed in the urine and other supplements like D glucarate and glycine. So you're, once again, you're trying to get them kicked out so you can visualize them on a, a test result and have a metric to then compare and create their treatment plans. So once this is done, and we know their food sensitivities via a blood test and their gut microbiome via a stool test, that builds out a complete picture of this patient's current state of inflammation, how we can lower it, how we can detox them, and then we go through basically a phase one detox using cellcore as our detoxification supplement line. So once again, to summarize, we look at all of these parameters, we look at functional genomics, we look at toxicity testing, gut microbiome, food sensitivities, and hormone balance to set our patients up for success with fat transfer. That's how we get the best outcome.
